BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8968753)

  • 1. Expression of the ceruloplasmin gene in the human retina and brain: implications for a pathogenic model in aceruloplasminemia.
    Klomp LW; Gitlin JD
    Hum Mol Genet; 1996 Dec; 5(12):1989-96. PubMed ID: 8968753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceruloplasmin gene expression in the murine central nervous system.
    Klomp LW; Farhangrazi ZS; Dugan LL; Gitlin JD
    J Clin Invest; 1996 Jul; 98(1):207-15. PubMed ID: 8690795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aceruloplasminemia.
    Kono S
    Curr Drug Targets; 2012 Aug; 13(9):1190-9. PubMed ID: 22515740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and pathological basis of aceruloplasminemia.
    Kono S; Miyajima H
    Biol Res; 2006; 39(1):15-23. PubMed ID: 16629161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
    Harris ZL; Klomp LW; Gitlin JD
    Am J Clin Nutr; 1998 May; 67(5 Suppl):972S-977S. PubMed ID: 9587138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aceruloplasminemia].
    Miyajima H
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1290-2. PubMed ID: 11464482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aceruloplasminemia: an inherited neurodegenerative disease with impairment of iron homeostasis.
    Xu X; Pin S; Gathinji M; Fuchs R; Harris ZL
    Ann N Y Acad Sci; 2004 Mar; 1012():299-305. PubMed ID: 15105274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aceruloplasminemia: an update.
    Kono S
    Int Rev Neurobiol; 2013; 110():125-51. PubMed ID: 24209437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aceruloplasminemia.
    Gitlin JD
    Pediatr Res; 1998 Sep; 44(3):271-6. PubMed ID: 9727700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aceruloplasminemia.
    Miyajima H
    Neuropathology; 2015 Feb; 35(1):83-90. PubMed ID: 25168455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuronal cell damage in aceruloplasminemia].
    Miyajima H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2000 Oct; 20(4):161-7. PubMed ID: 11215401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis.
    Vila Cuenca M; Marchi G; Barqué A; Esteban-Jurado C; Marchetto A; Giorgetti A; Chelban V; Houlden H; Wood NW; Piubelli C; Dorigatti Borges M; Martins de Albuquerque D; Yotsumoto Fertrin K; Jové-Buxeda E; Sanchez-Delgado J; Baena-Díez N; Burnyte B; Utkus A; Busti F; Kaubrys G; Suku E; Kowalczyk K; Karaszewski B; Porter JB; Pollard S; Eleftheriou P; Bignell P; Girelli D; Sanchez M
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceruloplasmin replacement therapy ameliorates neurological symptoms in a preclinical model of aceruloplasminemia.
    Zanardi A; Conti A; Cremonesi M; D'Adamo P; Gilberti E; Apostoli P; Cannistraci CV; Piperno A; David S; Alessio M
    EMBO Mol Med; 2018 Jan; 10(1):91-106. PubMed ID: 29183916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aceruloplasminemia, an iron metabolic disorder.
    Miyajima H
    Neuropathology; 2003 Dec; 23(4):345-50. PubMed ID: 14719552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of ceruloplasmin in the retina: induction after optic nerve crush.
    Levin LA; Geszvain KM
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):157-63. PubMed ID: 9430557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of desferrioxamine in the treatment of aceruloplasminemia.
    Miyajima H; Takahashi Y; Kamata T; Shimizu H; Sakai N; Gitlin JD
    Ann Neurol; 1997 Mar; 41(3):404-7. PubMed ID: 9066364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aceruloplasminemia in a Turkish adolescent with a novel mutation of ceruloplasmin gene: the first diagnosed case from Turkey.
    Meral Gunes A; Sezgin Evim M; Baytan B; Iwata A; Hida A; Avci R
    J Pediatr Hematol Oncol; 2014 Oct; 36(7):e423-5. PubMed ID: 25247888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aceruloplasminemia: molecular characterization of this disorder of iron metabolism.
    Harris ZL; Takahashi Y; Miyajima H; Serizawa M; MacGillivray RT; Gitlin JD
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2539-43. PubMed ID: 7708681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased very long-chain fatty acids in erythrocyte membranes of patients with aceruloplasminemia.
    Miyajima H; Adachi J; Tatsuno Y; Takahashi Y; Fujimoto M; Kaneko E; Gitlin JD
    Neurology; 1998 Jan; 50(1):130-6. PubMed ID: 9443469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of heterozygosis for aceruloplasminemia.
    Borges MD; de Albuquerque DM; Lanaro C; Costa FF; Fertrin KY
    Am J Med Genet B Neuropsychiatr Genet; 2019 Jun; 180(4):266-271. PubMed ID: 30901137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.